| # | Drug | Count |
|---|---|---|
| 0 | METHYLPREDNISOLONE | 4 |
| 1 | TACROLIMUS | 3 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 |
| 3 | TACROLIMUS OINTMENT 0.1% | 3 |
| 4 | MYCOPHENOLATE MOFETIL | 2 |
| 5 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 2 |
| 6 | ALEMTUZUMAB | 1 |
| 7 | AMPHOTERICIN B LIPOSOME | 1 |
| 8 | AZATHIOPRINE | 1 |
| 9 | CYCLOPHOSPHAMIDE | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLUCYTOSINE | 1 | 0.0007 |
| 1 | AMPHOTERICIN B LIPOSOME | 1 | 0.0004 |
| 2 | ITRACONAZOLE | 1 | 0.0001 |
| 3 | ALEMTUZUMAB | 1 | 0.0001 |
| 4 | RABEPRAZOLE SODIUM | 1 | 0.0000 |
| 5 | VORICONAZOLE | 1 | 0.0000 |
| 6 | METHYLPREDNISOLONE | 4 | 0.0000 |
| 7 | TACROLIMUS OINTMENT 0.1% | 3 | 0.0000 |
| 8 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 3 | 0.0000 |
| 9 | TACROLIMUS | 3 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 1 | Lipid-based Polyene Antifungal [EPC] | 1 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 3 | Polyene Antifungal [EPC] | 1 | 0.0000 |
| 4 | Purine Antimetabolite [EPC] | 1 | 0.0000 |
| 5 | Calcineurin Inhibitor Immunosuppressant [EPC] | 1 | 0.0000 |
| 6 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 7 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 8 | Corticosteroid [EPC] | 5 | 0.0000 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |